The Era of Cuffless Blood Pressure Monitoring: Introducing 'CART BP pro'

Introduction to CART BP pro

The landscape of blood pressure monitoring has just undergone a revolutionary shift with the introduction of the 'CART BP pro' by Sky Labs. Officially launched and included in the 2026 Korean Hypertension Society guidelines, this innovative device symbolizes the end of the era dominated by traditional cuff-based blood pressure monitors.

What is CART BP pro?

CART BP pro is a cuffless ring-type blood pressure monitor designed to be worn on the finger. This sleek and practical device allows for continuous blood pressure monitoring throughout the day and night, offering significant improvements over traditional monitoring methods.

Official Endorsement

Standing out as the first ring-type monitor to be incorporated into official hypertension treatment guidelines, the KSH (Korean Society of Hypertension) has recognized its clinical relevance. This historic endorsement positions Korea at the forefront of global medical standards regarding cuffless technology in blood pressure monitoring. The transition towards more user-friendly and less invasive monitoring practices could have profound implications not only for patients but also for healthcare providers.

Encouraged Use Among Patients

Under the new guidelines, the KSH emphasizes recommending devices like CART BP pro for at-home blood pressure monitoring, particularly in high-risk groups such as those dealing with prehypertension and chronic conditions like diabetes or kidney disease. A revised target of less than 130/80 mmHg has been established to improve management for these patients, indicating a more active role in self-monitoring blood pressure management.

Key Clinical Findings

A thorough analysis of studies included in the guidelines reveals compelling supporting evidence for the efficacy of the CART BP pro. In comparative studies, it demonstrated correlation with traditional Auscultatory measurements and met ISO 81060-2:2018 standards, maintaining deviations well within acceptable limits. This has led to a wave of interest not just from the local medical community but internationally as well.

Addressing Common Hypertension Issues

CART BP pro is particularly adept at identifying nuanced conditions such as nocturnal hypertension and morning hypertension, which can often go undetected during conventional check-ups. Reports indicate that around 18% to 23% of patients face undiagnosed nighttime hypertension, characterized by elevated blood pressure during sleep. Given this, CART BP pro fills a crucial gap, providing unobtrusive monitoring and enabling informed treatment decisions.

Broadening Access to Advanced Monitoring

Since its introduction in 2024, the CART BP pro has been utilized in over 1,920 hospitals across South Korea, reflecting a rapid acceptance among healthcare practitioners. It has also received national health insurance coverage, making it accessible to more patients and allowing healthcare providers to incorporate it into routine care more seamlessly. Over 250,000 prescriptions have been recorded, illustrating its growing acceptance and utility in clinical settings.

Future Directions for CART BP pro

Sky Labs plans to leverage this clinical success to pursue international regulatory approvals, aspiring to establish a new global standard for hypertension management. As stated by Jack ByungHwan Lee, CEO of Sky Labs, "The inclusion of CART BP pro in KSH guidelines underscores Korea’s leadership in setting the clinical standard for cuffless blood pressure monitoring technology."

Conclusion

With innovative designs and empirical backing, CART BP pro signifies a pivotal moment in hypertension treatment. It addresses the limitations of previous methods while advocating for patient-centered blood pressure management strategies. As the healthcare industry moves towards more technology-driven solutions, CART BP pro sets a benchmark for what the future of blood pressure monitoring can achieve.